ETF Holdings Breakdown of ABBV

News associated with ABBV

AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Guggenheim Analyst Says

AbbVie (NYSE:ABBV – Get Free Report) had its price target hoisted by equities researchers at Guggenheim from $214.00 to $216.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Guggenheim’s price objective would indicate a potential upside of 10.68% from the company’s previous close. Several other […] - 2025-05-01 07:44:54

AbbVie (NYSE:ABBV) Shares Up 0.7% After Analyst Upgrade

AbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price shot up 0.7% on Tuesday after Guggenheim raised their price target on the stock from $214.00 to $216.00. Guggenheim currently has a buy rating on the stock. AbbVie traded as high as $194.16 and last traded at $193.70. 1,669,926 shares were traded during trading, a decline […] - 2025-05-01 06:14:49

AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Evercore ISI Analyst Says

AbbVie (NYSE:ABBV – Get Free Report) had its price objective lifted by analysts at Evercore ISI from $204.00 to $205.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Evercore ISI’s target price suggests a potential upside of 5.92% from the company’s current price. Several other equities […] - 2025-04-30 07:54:52

Morgan Stanley Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock

AbbVie (NYSE:ABBV – Get Free Report) had its price objective increased by Morgan Stanley from $241.00 to $250.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 29.17% from the company’s current price. Other equities research analysts have […] - 2025-04-30 07:54:48

AbbVie (NYSE:ABBV) Shares Up 1.8% on Better-Than-Expected Earnings

AbbVie Inc. (NYSE:ABBV – Get Free Report)’s share price shot up 1.8% on Monday after the company announced better than expected quarterly earnings. The company traded as high as $191.32 and last traded at $189.41. 2,998,309 shares were traded during trading, a decline of 50% from the average session volume of 6,034,044 shares. The stock […] - 2025-04-30 05:51:08

Pre-Market Most Active for Apr 28, 2025 : TSLL, PFE, BBAI, INTC, NVDA, TSLA, SWTX, TQQQ, AMPY, SCHW, ABBV, NIO

The NASDAQ 100 Pre-Market Indicator is down -14.2 to 19,418.36. The total Pre-Market volume is currently 170,511,986 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.27 at $10.72, with 25,789,199 s - 2025-04-28 12:28:55

AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of AbbVie (NYSE:ABBV – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat reports. The firm issued an overweight rating and a $210.00 target price on the stock. Several other brokerages have also issued reports on ABBV. Truist Financial boosted their price target on AbbVie […] - 2025-04-23 08:12:54

AbbVie (NYSE:ABBV) Lowered to Buy Rating by StockNews.com

AbbVie (NYSE:ABBV – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday. Other equities analysts also recently issued research reports about the stock. Guggenheim raised their target price on shares of AbbVie from $212.00 to $214.00 and gave the […] - 2025-04-11 07:28:53

Noteworthy ETF Outflows: BKLC, MA, COST, ABBV

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the BNY Mellon US Large Cap Core Equity ETF (Symbol: BKLC) where we have detected an approximate $511.6 million dollar outflow -- that's a 18.1% decreas - 2025-04-09 14:50:06

After Hours Most Active for Apr 2, 2025 : RIG, TSLL, IGSB, NVDA, LCID, TQQQ, FTRE, VZ, ABBV, PFE, T, F

The NASDAQ 100 After Hours Indicator is down -624.55 to 18,957.23. The total After hours volume is currently 151,336,280 shares traded.The following are the most active stocks for the after hours session: Transocean Ltd. (RIG) is -0.0096 at $3.15, with 12,076,585 shares traded. - 2025-04-02 20:24:58

Notable ETF Outflow Detected - DGRO, ABBV, CME, CSCO

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Dividend Growth ETF (Symbol: DGRO) where we have detected an approximate $982.3 million dollar outflow -- that's a 3.1% decrease week o - 2025-04-01 15:00:25

Noteworthy Tuesday Option Activity: ADBE, ABBV, WMT

Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Adobe Inc (Symbol: ADBE), where a total of 20,241 contracts have traded so far, representing approximately 2.0 million underlying shares. That amounts to about 46.3% of A - 2025-03-25 18:19:40

DGRO, ABBV, JNJ, JPM: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Dividend Growth ETF (Symbol: DGRO) where we have detected an approximate $1.1 billion dollar inflow -- that's a 3.7% increase week over - 2025-03-24 15:24:42

Noteworthy ETF Inflows: IWD, WMT, CSCO, ABBV

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $255.9 million dollar inflow -- that's a 0.4% increase week over w - 2025-03-14 15:06:00

Rep. Jefferson Shreve Purchases Shares of AbbVie Inc. (NYSE:ABBV)

Representative Jefferson Shreve (R-Indiana) recently bought shares of AbbVie Inc. (NYSE:ABBV). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $50,001 and $100,000 in AbbVie stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account. Representative Jefferson Shreve also recently made the following […] - 2025-03-12 06:36:43

VTV, WMT, ABBV, CSCO: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Value ETF (Symbol: VTV) where we have detected an approximate $1.0 billion dollar inflow -- that's a 0.8% increase week over week in outstan - 2025-03-06 16:21:27

Bank of America Raises AbbVie (NYSE:ABBV) Price Target to $223.00

AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by equities research analysts at Bank of America from $200.00 to $223.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Bank of America‘s price objective suggests a potential upside of 5.38% from the stock’s previous […] - 2025-03-06 10:24:59

AbbVie (NYSE:ABBV) Shares Up 0.6% Following Analyst Upgrade

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0.6% on Wednesday after Wells Fargo & Company raised their price target on the stock from $210.00 to $240.00. Wells Fargo & Company currently has an overweight rating on the stock. AbbVie traded as high as $211.13 and last traded at $209.01. 1,149,669 shares […] - 2025-03-06 08:55:58

AbbVie Reaches Analyst Target Price

In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $207.60, changing hands for $209.03/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati - 2025-03-03 12:46:52

AbbVie, Gubra Enter License Agreement To Develop GUB014295 - Quick Facts

(RTTNews) - AbbVie (ABBV) and Gubra A/S announced a license agreement to develop GUB014295, a potential long-acting amylin analog for the treatment of obesity. AbbVie will lead development and commercialization activities of GUB014295 globally. Gubra will receive $350 million in - 2025-03-03 06:26:52

AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?

AbbVie has outperformed the healthcare sector over the past year, and analysts are moderately optimistic about the stock’s prospects. - 2025-02-28 18:26:29

AbbVie's Upadacitinib Gets Positive CHMP Opinion For Treatment Of Adults With Giant Cell Arteritis

(RTTNews) - AbbVie (ABBV) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib (RINVOQ; 15 mg, once daily) for the treatment of adult patients with giant cell arte - 2025-02-28 07:33:37

Strategic Financial Concepts LLC Acquires 845 Shares of AbbVie Inc. (NYSE:ABBV)

Strategic Financial Concepts LLC boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 56.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,329 shares of the company’s stock after purchasing an additional 845 shares during […] - 2025-02-21 09:07:04

Daily Dividend Report: RHI,CSCO,ABBV,PSX,MDLZ

Robert Half today announced that its board of directors has approved an increase to its quarterly cash dividend, from $0.53 to $0.59 per share. The cash dividend will be paid on March 14, 2025, to all shareholders of record as of Feb. 25, 2025. Cisco has declared a quarterly di - 2025-02-13 17:50:05

Leerink Partnrs Estimates AbbVie’s Q1 Earnings (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a research note issued to investors on Monday, February 3rd. Leerink Partnrs analyst D. Risinger anticipates that the company will post earnings of $2.50 per share for the […] - 2025-02-06 07:10:47

Is Wall Street Bullish or Bearish on AbbVie Stock?

Despite AbbVie's underperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock's future. - 2025-02-05 12:35:42

AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

AbbVie (NYSE:ABBV – Get Free Report) had its target price raised by equities research analysts at Wells Fargo & Company from $195.00 to $210.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 10.54% […] - 2025-02-05 12:27:09

AbbVie (NYSE:ABBV) Price Target Raised to $190.00 at UBS Group

AbbVie (NYSE:ABBV – Get Free Report) had its price target lifted by equities researchers at UBS Group from $181.00 to $190.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential upside of 0.01% from the stock’s previous close. […] - 2025-02-05 12:27:04

Citigroup Boosts AbbVie (NYSE:ABBV) Price Target to $215.00

AbbVie (NYSE:ABBV – Get Free Report) had its price objective upped by stock analysts at Citigroup from $205.00 to $215.00 in a report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Citigroup’s price objective would indicate a potential upside of 13.17% from the company’s previous close. ABBV has been […] - 2025-02-05 10:07:16

Guggenheim Raises AbbVie (NYSE:ABBV) Price Target to $214.00

AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by stock analysts at Guggenheim from $212.00 to $214.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective would suggest a potential upside of 12.65% from the stock’s previous close. […] - 2025-02-05 09:24:56

ABBV institutional holdings

Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119 Stack trace: #0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query() #1 {main} thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119

Date	ETF ISIN/Name	Num Shares	Book value